Mary T. Szela, CEO and President at TriSalus Life Sciences, Inc. (TLSI), bought 39,682 shares at $2.59 ($103K) on 2026-05-15, disclosed to the SEC on 2026-05-18.
CEO Mary T. Szela purchased $102,776 worth of shares at $2.59, marking the largest purchase of her career. This bullish bet comes as the stock has plummeted over 34% in the last 30 days, potentially signaling confidence in the recent dip.
TLSI is currently trading at $3.02, down 34.98% over the last 30 days and 41.25% over the past year. The stock is currently 62.01% below its 52-week high of $7.95.
Something here stands out, but not much.
| Filing → |
| TLSI | BUY | 2026-02-23 | $125K | — | Filing → |
| TLSI | BUY | 2025-01-31 | $52K | — | Filing → |
| TLSI | BUY | 2025-01-29 | $50K | — | Filing → |